Victory Capital Management Inc Enanta Pharmaceuticals Inc Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$40.77 - $53.73 $538,571 - $709,773	-13,210 Reduced 76.23%	4,120 $191,000
Q3 2022 Nov 02, 2022	SELL	$48.29 - $71.27 $86,583 - $127,787	-1,793 Reduced 9.38%	17,330 $899,000
Q2 2022 Aug 01, 2022	BUY	$38.13 - $76.93 $114,733 - $231,482	3,009 Added 18.67%	19,123 $904,000
Q1 2022 May 04, 2022	BUY	$56.06 - $74.11 $485,311 - $641,570	8,657 Added 116.09%	16,114 $1.04 Million
Q4 2021 Feb 07, 2022	BUY	$60.19 - $97.37 $448,836 - $726,088	7,457 New	7,457 $558,000
Q2 2021 Aug 03, 2021	SELL	$43.76 - $53.11 $223,219 - $270,914	-5,101 Closed	0 $0
Q1 2021 May 04, 2021	SELL	$41.69 - $54.95 $66,412 - $87,535	-1,593 Reduced 23.8%	5,101 $252,000
Q4 2020 Feb 01, 2021	BUY	$41.16 - $47.47 $27,865 - $32,137	677 Added 11.25%	6,694 $282,000
Q3 2020 Nov 09, 2020	SELL	$43.36 - $53.53 $435,464 - $537,601	-10,043 Reduced 62.53%	6,017 $275,000
Q2 2020 Aug 07, 2020	BUY	$46.37 - $57.58 $558,712 - $693,781	12,049 Added 300.4%	16,060 $806,000
Q1 2020 May 04, 2020	SELL	$40.22 - $62.0 $39,616 - $61,070	-985 Reduced 19.72%	4,011 $206,000
Q4 2019 Feb 06, 2020	BUY	$57.95 - $66.61 $31,524 - $36,235	544 Added 12.22%	4,996 $309,000
Q4 2019 Feb 04, 2020	BUY	$57.95 - $66.61 $5,215 - $5,994	90 Added 2.06%	4,452 $229,000
Q3 2019 Nov 12, 2019	BUY	$60.08 - $88.17 $214,425 - $314,678	3,569 Added 450.06%	4,362 $262,000
Q2 2019 Aug 15, 2019	SELL	$81.3 - $97.35 $111,950 - $134,050	-1,377 Reduced 63.46%	793 $67,000
Q1 2019 May 03, 2019	SELL	$69.08 - $105.66 $55,885 - $85,478	-809 Reduced 27.16%	2,170 $207,000
Q4 2018 Feb 05, 2019	BUY	$65.41 - $84.65 $7,587 - $9,819	116 Added 4.05%	2,979 $211,000
Q3 2018 Nov 01, 2018	BUY	$85.46 - $126.37 $244,671 - $361,797	2,863 New	2,863 $245,000

Others Institutions Holding ENTA

# of Institutions

110

Shares Held

21.1M

Call Options Held

4.8K

Put Options Held

4.6K

Farallon Capital Management LLC San Francisco, CA

2.11M
Shares

$19.7 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

1.98M
Shares

$18.5 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.85M
Shares

$17.3 Million
0.0% of portfolio
Krensavage Asset Management, LLC New York, NY

1.5M
Shares

$14 Million
8.7% of portfolio
Morgan Stanley New York, NY

1.1M
Shares

$10.3 Million
0.0% of portfolio

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $194M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account